Vena Medical GTM brain

category

market profile

• text: Angiography shows a lumen silhouette while intravascular ultrasound and OCT provide interpreted cross-sectional views; Vena offers direct forward visualization alongside existing tools.
• text: Indications vary: the Canadian page includes neurovasculature, while the US page specifies peripheral and coronary vessels.

personas

• title: Interventional radiologist or vascular surgeon
  pains:

  • Must navigate complex vascular anatomy with indirect or cross-sectional imaging.
  • Needs to assess vessel surfaces and device interfaces during a procedure.
• title: Neurointerventional physician in Canada
  pains:

  • Conventional angiography cannot directly show all intracranial vessel and implant details.
  • New visualization tools require evidence and integration into established procedural workflows.
• title: Hospital vascular lab director or procurement lead
  pains:

  • Must assess clinical utility, indications, device compatibility and acquisition cost.
  • New equipment competes for constrained procedure budgets and clinician training time.

icp

• text: Canadian hospitals with neurovascular, coronary or peripheral intervention programs and appropriate licensed use.
• text: US hospitals and outpatient vascular intervention programs evaluating direct visualization for peripheral or coronary vessels.
• text: Specialist centers with existing angiosuite monitors and physicians interested in procedural imaging innovation.

message pillars

• text: Give clinicians a direct view inside vessels.
• text: Deliver live forward-looking color visualization.
• text: Fit visualization into the existing procedure room.

objections

• objection: Is this cleared for our procedure and geography?
  response: Review current local labeling and instructions for use; US and Canadian indications differ.
• objection: Does direct visualization improve our workflow enough to justify procurement?
  response: Review published clinical evidence and arrange a clinician-led demonstration for the intended use.

competitors

• name: Olympus
  why: Its AF angioscope is an FDA predicate device, a related visualization alternative rather than a claim of identical use.
• name: Stryker
  why: Offers vascular access and imaging-adjacent devices used in neurovascular interventions; an indirect procedural budget competitor.
• name: Terumo Neuro
  why: Offers neurovascular access catheters; an indirect alternative for procedure workflows, not an equivalent camera.

keywords

• microangioscopy vascular imaging
• intravascular camera
• direct vessel visualization
• neurovascular angioscopy Canada
• peripheral vascular angioscope
• endovascular imaging catheter

voice

• clinical
• visual
• innovation-focused

signals

• text: A vascular center is assessing new endovascular imaging or visualization technology.
• text: A Canadian neurointerventional program publishes research or evaluates new vascular imaging workflows.

pricing

motion

channels

• clinical conferences
• clinical education
• hospital demonstrations

confidence

Founders

• name: Michael Phillips
  title: Founder
  role: Founder
  bio: Graduated from University of Waterloo with a Bachelor of Applied Science (B.A.Sc.) focused in Mechanical Engineering with an Entrepreneurship Option. Michael co-founded Vena Medical during the final year of his undergraduate degree and went full-time immediately after graduating. Attended TMCx Accelerator and Y Combinator in the year following. Published author in the Journal of Neuro-Interventional Surgery and the American Journal of Neuroradiology, and inventor on 5 granted patents.
• name: Phillip Cooper
  title: Founder
  role: Founder